- Home
- SBFM vs OVBC Comparison
SBFM vs OVBC Comparison
Compare SBFM & OVBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- OVBC
- Stock Information
- Founded
- SBFM 2006
- OVBC 1872
- Country
- SBFM United States
- OVBC United States
- Employees
- SBFM N/A
- OVBC N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- OVBC Major Banks
- Sector
- SBFM Health Care
- OVBC Finance
- Exchange
- SBFM Nasdaq
- OVBC Nasdaq
- Market Cap
- SBFM 4.9M
- OVBC N/A
- IPO Year
- SBFM N/A
- OVBC N/A
- Fundamental
- Price
- SBFM $1.35
- OVBC $38.89
- Analyst Decision
- SBFM Strong Buy
- OVBC
- Analyst Count
- SBFM 1
- OVBC 0
- Target Price
- SBFM $15.00
- OVBC N/A
- AVG Volume (30 Days)
- SBFM 4.3M
- OVBC 12.2K
- Earning Date
- SBFM 05-19-2025
- OVBC 04-28-2025
- Dividend Yield
- SBFM N/A
- OVBC 2.35%
- EPS Growth
- SBFM N/A
- OVBC N/A
- EPS
- SBFM N/A
- OVBC 2.32
- Revenue
- SBFM $34,874,283.00
- OVBC $59,506,000.00
- Revenue This Year
- SBFM $192.48
- OVBC N/A
- Revenue Next Year
- SBFM N/A
- OVBC N/A
- P/E Ratio
- SBFM N/A
- OVBC $16.75
- Revenue Growth
- SBFM 44.75
- OVBC 5.20
- 52 Week Low
- SBFM $1.17
- OVBC $19.35
- 52 Week High
- SBFM $33.60
- OVBC $40.99
- Technical
- Relative Strength Index (RSI)
- SBFM 34.08
- OVBC 76.07
- Support Level
- SBFM $1.17
- OVBC $28.50
- Resistance Level
- SBFM $1.59
- OVBC $40.99
- Average True Range (ATR)
- SBFM 0.33
- OVBC 2.24
- MACD
- SBFM -0.01
- OVBC 1.15
- Stochastic Oscillator
- SBFM 6.63
- OVBC 85.30
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.